Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Tocilizumab

Tag: Tocilizumab

  • BiotechToday
  • World

Tocilizumab and Sarilumab receives WHO Approval for critically-ill Patients

BioTech Today July 9, 2021July 8, 2021 1

Agrima Bhatt, Rajasthan University Current Scenario The emergence of coronavirus from 2019 till now has led to a global healthcare crisis all over the world. Recent data of COVID-19 shows data as of July 7 having 184,324,026 confirmed cases and 3,992,680 deaths. Although vaccination has started to pick up pace in many countries, the risk […]

Read More
  • BiotechToday
  • India

Drugs like ivermectin, doxycycline, Hydroxychloroquine removed in revised Covid-19 guidelines

BioTech Today June 14, 2021June 14, 2021 1

Saptaparna Pal, Amity University Kolkata The Union Health Ministry’s Directorate General of Health Sciences (DGHS) has proposed revised Covid-19 guidelines and removed all medicines except antipyretic (fever) and antitussive (cold) for mild and asymptomatic cases. The revised Covid-19 guidelines issued on 27 May 2021 dropped all medicines that the doctors have been prescribing even to […]

Read More
  • BiotechToday
  • World

DO COVID-19 PATIENTS BENEFIT FROM TOCILIZUMAB AT ALL?

bioxone October 25, 2020October 25, 2020

Arpan Banerjee, University of Calcutta Since the time Covid-19 has plagued the entire world, many studies have evolved emphasizing its heterogeneous clinical presentation, ranging from silent asymptomatic carriers to the severe ones bogged down with respiratory failure. The clinical trials about the finding of the wonder drug is still awaited. In the meantime, several drugs […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy